Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)

Biosimilar adoption is hindered by complex interchangeability requirements. Pharmacists must be equipped with educational resources and training that ensures confidence among biosimilar interchangeability to create meaningful change. The BBCIC's scientists, researchers, and contributors develop proposals, presentations, and new discoveries in the ever-evolving realm of biosimilars. Even Ivan our scientist pup takes quality seriously! https://bit.ly/32zdw4W #Testing #Trust #GlobalBiosimilarsWeek

#Biosimilars go through rigorous training to show they can work just as well as the originals. Sometimes in their rigorous training, a pup is trained to sniff things out for a safe walk down the block. https://bit.ly/2Gh5MvW #EquivalentStrength #GlobalBiosimilarsWeek

Have you ever wondered what Ivan, the most informed beagle in managed care pharmacy, talks with his friends about? They are talking about the exciting developments going on with BBCIC during #GlobalBiosimilarsWeek. Learn more: https://bit.ly/2Tyebyun #biosimilars #MCPs

As we celebrate #GlobalBiosimilarWeek 2024, hear from AMCP's Chief Science Officer & Executive Director of BBCIC, Cate Lockhart, PharmD, PhD about what AMCP is doing to participate in the development of #biosimilars across the world. Learn more: https://bit.ly/48F8pkg

It's been 40 years since the passage of the Hatch-Waxman Act, the historic legislation that established today's generic pharmaceutical industry. With rising costs for innovative therapies, where does the legacy of the Act stand four decades later? https://onphr.ma/4diEXS4 PhRMA Henry Waxman

Throwback Thursday to BBCIC's Patrick Pithua presenting at ISPOR—The Professional Society for Health Economics and Outcomes Research in Atlanta, Ga. The poster describes BBCIC's literature review determining methods for measuring medication adherence using claims and other secondary data sources. BBCIC is most interested in how to measure adherence for medications that have variable dosing like insulins or treatments for rheumatoid arthritis. Visit us online to view the poster: https://bit.ly/3SHO5bu #BBCIC #rheumatoidarthritis

We had a fantastic participant meeting at our Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Annual Meeting this week! We covered a lot of topics including a workshop session where we learned and practiced summarizing some of our recent peer-reviewed publications into patient-centered abstracts. The goal is to do the same with all of our research publications now and in the future. Thank you for your enthusiasm!

Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) represented at #ASX24 this week!